ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2471

Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use

Borja del Carmelo Gracia Tello1, Gema María Lledó Ibáñez2, Luis Sáez Comet3 and Eduardo Ramos ibáñez4, 1Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 2Hospital Clínic de Barcelona, Barcelona, Spain, 3Hospital Universitario Miguel Servet, Zaragoza, Spain, 4Capillary.io, Zaragoza, Aragon, Spain

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, informatics, Raynaud's, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Nailfold capillaroscopy is a key tool in the early diagnosis of systemic sclerosis and related disorders. However, incorrect image acquisition can lead to misclassification of capillaroscopic patterns, potentially delaying diagnosis and affecting clinical decisions.To support clinical reliability we developed a lightweight, real-time system for automatic quality assessment of nailfold capillaroscopy (NFC) images. The system supports exclusion of invalid images from analysis and reporting, provides immediate feedback during image acquisition, and aids clinician training by detecting typical image acquisition problems during a capillaroscopy examination.

Methods: A small and efficient deep learning model based on the ConvNeXt V2 architecture was trained to identify frequent NFC image issues: low magnification, blurring, reflections, incorrect placement, underexposure, and invalid content. For valid images (those without problems), the model also estimates diagnostic usability as low quality or acceptable quality.Low quality images were defined as diagnostically acceptable but with imperfect focus or suboptimal capillary visibility, while acceptable quality images had clear visualization suitable for confident pattern recognition.The model was trained on a dataset of 10,866 annotated images. An image may have multiple problem annotations, but quality grading (low or acceptable) was applied only to images without any problems. The number of annotations per annotation type are shown in Table 1.To ensure clinical reliability, model evaluation metrics were computed at a confidence threshold of 0.85.

Results: The model achieved exceptional performance in detecting low magnification images, with an F1-score of 0.99, and invalid content, with an F1-score of 0.96, two of the most critical categories for ensuring diagnostic image quality. It also showed strong performance in identifying blurry images (F1 = 0.84) and those with excessive reflections (F1 = 0.83).In terms of quality grading of valid images, the model effectively distinguished between low and acceptable quality among valid images, achieving an F1-score of 0.8316 for low-quality cases. The rest of performance metrics are shown in Table 2.

Conclusion: This real-time model based on ConvNeXt V2 helps ensure that nailfold capillaroscopy examinations are useful and valid. It automatically detects common problems in images and checks whether valid images have enough quality for diagnosis. Because it is fast and lightweight, it can be used during image capture to give immediate feedback, avoid invalid images, and improve the consistency of capillaroscopies. This makes the process more efficient and helps both clinicians and researchers achieve better, more reliable results as well as being a useful tool in the training of new physicians.

Supporting image 1Table 1. Number of annotations per class

Supporting image 2Table 2. Performance metrics per class


Disclosures: B. Gracia Tello: None; G. Lledó Ibáñez: None; L. Sáez Comet: None; E. Ramos ibáñez: None.

To cite this abstract in AMA style:

Gracia Tello B, Lledó Ibáñez G, Sáez Comet L, Ramos ibáñez E. Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/automated-feedback-and-quality-control-in-nailfold-capillaroscopy-a-tool-for-clinical-and-educational-use/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automated-feedback-and-quality-control-in-nailfold-capillaroscopy-a-tool-for-clinical-and-educational-use/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology